Illumina
ILMN
$90.26
Share price
0.88%
Change (1 day)
-14.17%
Change (1 year)
Categories
Revenue for Illumina (ILMN)
Revenue in 2025 (TTM): $4.33 Billion USD
According to Illumina's latest financial reports the company's current revenue (TTM 
) is $4.33 Billion USD. In 2024 the company made a revenue of $4.37 Billion USD a decrease over the revenue in the year 2023 that were of $4.50 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Illumina from 2000 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | $4.33 B | -0.8% |
| 2024 | $4.37 B | -2.93% |
| 2023 | $4.50 B | -1.72% |
| 2022 | $4.58 B | 1.26% |
| 2021 | $4.52 B | 39.73% |
| 2020 | $3.23 B | -8.58% |
| 2019 | $3.54 B | 6.33% |
| 2018 | $3.33 B | 21.12% |
| 2017 | $2.75 B | 14.7% |
| 2016 | $2.39 B | 8.05% |
| 2015 | $2.21 B | 19.25% |
| 2014 | $1.86 B | 30.97% |
| 2013 | $1.42 B | 23.74% |
| 2012 | $1.14 B | 8.81% |
| 2011 | $1.05 B | 16.93% |
| 2010 | $0.90 B | 35.48% |
| 2009 | $0.66 B | 16.24% |
| 2008 | $0.57 B | 56.28% |
| 2007 | $0.36 B | 98.71% |
| 2006 | $0.18 B | 151.13% |
| 2005 | $73.5 M | 45.3% |
| 2004 | $50.58 M | 80.43% |
| 2003 | $28.03 M | 179.23% |
| 2002 | $10.04 M | 303.76% |
| 2001 | $2.48 M | 89.95% |
| 2000 | $1.3 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 PerkinElmer
PKI | $3.35 B | -22.59% | 🇺🇸 USA |
 Pacific Biosciences
PACB | $0.15 B | -96.49% | 🇺🇸 USA |
 Agilent Technologies A | $6.62 B | 52.82% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | $42.89 B | 889.12% | 🇺🇸 USA |
 Translate Bio
TBIO.defunct | $0.22 B | -94.81% | 🇺🇸 USA |
 Danaher DHR | $23.82 B | 449.23% | 🇺🇸 USA |
 Luminex LMNX | N/A | N/A | 🇺🇸 USA |
 Quest Diagnostics
DGX | $10.15 B | 134.22% | 🇺🇸 USA |